Table 2.
Outcomes at 30- and 180-day follow-up, total sample
| Control (n = 217) | Intervention (n = 212) | p value | |
|---|---|---|---|
| Drug-related readmissions | |||
| Drug-related readmissions, no. | 68 | 58 | 0.32 |
| Certain (no. of individual patientsa) | 3 (3) | 3 (3) | |
| Probable (no. of individual patientsa) | 25 (22) | 24 (16) | |
| Possible (no. of individual patientsa) | 40 (25) | 31 (23) | |
| Patients readmitted because of DRP, no. (%) | 50 (23) | 40 (19) | 0.29 |
| Patients readmitted because of DRP within 30 days, no. (%) | 24 (11) | 11 (5) | 0.03 |
| Readmissions all causes | |||
| Patients readmitted, no. (%) | 88 (41) | 81 (38) | 0.62 |
| Readmissions, no. | 141 | 138 | 0.62 |
| Patients readmitted within 30 days, no. (%) | 40 (18) | 31 (15) | 0.29 |
| Mortality | |||
| Patients deceased | 34 (16%) | 44 (21%) | 0.17 |
DRP drug-related problems
aThe same person might have more than one type of drug-related readmission